°Ç¼± Ä¡·áÁ¦ ½ÃÀå : ¼¼°è »ê¾÷ ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Psoriasis Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
»óǰÄÚµå : 1773788
¸®¼­Ä¡»ç : Persistence Market Research
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 195 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,995 £Ü 7,035,000
Unprintable PDF & Excel (Single User License) help
PDF, Excel º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ º¹»ç, ÀμⰡ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 7,295 £Ü 10,275,000
PDF & Excel (Multi User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.
US $ 8,495 £Ü 11,965,000
PDF & Excel (Corporate User License) help
PDF, Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste¿Í ÀμⰡ °¡´ÉÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

Persistence Market Research´Â À̹ø¿¡ ¼¼°èÀÇ °Ç¼± Ä¡·áÁ¦ ½ÃÀå¿¡ °üÇÑ Á¾ÇÕÀû ºÐ¼®À» ¹ßÇ¥Çß½À´Ï´Ù. ½ÃÀå ¼ºÀå ÃËÁø¿äÀΡ¤µ¿Ç⡤±âȸ¡¤°úÁ¦ µîÀÇ Áß¿äÇÑ ½ÃÀå ¿ªÇÐÀ» öÀúÇÏ°Ô Æò°¡Çϰí, ½ÃÀå ±¸Á¶¿¡ °üÇÑ »ó¼¼ ÀλçÀÌÆ®¸¦ Á¦°øÇϰí ÀÖ½À´Ï´Ù. ¼¼°èÀÇ °Ç¼± Ä¡·áÁ¦ ½ÃÀåÀÇ ¿¹Ãø ¼ºÀå ±Ëµµ(2025-2032³â)¸¦ ¼³¸íÇÏ´Â µ¶Á¡Àû µ¥ÀÌÅÍ¿Í Åë°è¸¦ °ÔÀçÇϰí ÀÖ½À´Ï´Ù.

ÁÖ¿ä ÀλçÀÌÆ®

°Ç¼± Ä¡·áÁ¦ ½ÃÀå - ºÐ¼® ¹üÀ§

°Ç¼± Ä¡·áÁ¦ ½ÃÀå¿¡´Â ¸¸¼º ÀÚ°¡¸é¿ª¼º ÇǺÎÁúȯÀÎ °Ç¼±ÀÇ Áõ»óÀ» °ü¸®ÇÏ°í ¿ÏÈ­Çϱâ À§ÇÑ ´Ù¾çÇÑ ÀǾàǰ Ä¡·áÁ¦°¡ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ Ä¡·áÁ¦´Â ¿Ü¿ëÁ¦ºÎÅÍ Ã·´Ü »ý¹°Á¦Á¦ ¹× Àü½Å Åõ¿© ¾à¹°¿¡ À̸£±â±îÁö ´Ù¾çÇÕ´Ï´Ù. ÀνÄÀÇ ¹ßÀü, ÀǾàǰ °³¹ßÀÇ ±â¼úÀû Áøº¸, Àü ¼¼°è °Ç¼± À¯º´·ü Áõ°¡´Â º¸´Ù È¿°úÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä¸¦ Çü¼ºÇϰí ÀÖ½À´Ï´Ù. »ý¹°Á¦Á¦ÀÇ ±â¼ú Çõ½Å°ú ÇǺΰú ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë°¡ °è¼ÓÇØ¼­ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ:

°Ç¼± Ä¡·áÁ¦ ¼¼°è ½ÃÀå ¼ºÀåÀº °Ç¼± À¯º´·ü Áõ°¡¿Í ÀÎ½Ä ¹× Áø´ÜÀÇ Çâ»óÀ¸·Î ÀÎÇØ Ä¡·á¸¦ ¿øÇϴ ȯÀÚ°¡ Áõ°¡ÇÔ¿¡ ÀÇÇØ ÃËÁøµÇ°í ÀÖ½À´Ï´Ù. Ç¥ÀûÈ­µÇ°í È¿°úÀûÀÎ Ä¡·á¸¦ Á¦°øÇÏ´Â »ý¹°Á¦Á¦ÀÇ ±â¼ú ¹ßÀüÀ¸·Î Ä¡·á ¿É¼ÇÀÌ Å©°Ô È®´ëµÇ¾ú½À´Ï´Ù. ¼±Áø±¹ÀÇ À¯¸®ÇÑ »óȯ Á¤Ã¥°ú Á¦¾à»çµéÀÇ Áö¼ÓÀûÀÎ ¿¬±¸°³¹ß ³ë·Âµµ ÀǾàǰ ÆÄÀÌÇÁ¶óÀÎ °³¹ßÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ½ÅÈï ±¹°¡ÀÇ ÀÇ·á ÀÎÇÁ¶ó È®ÃæÀº °Ç¼± Ä¡·á¿¡ ´ëÇÑ Á¢±Ù¼º È®´ë¸¦ ÃËÁøÇÏ¿© ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ:

±àÁ¤ÀûÀÎ Àü¸Á¿¡µµ ºÒ±¸Çϰí ÀÌ ½ÃÀåÀº ÀáÀç·ÂÀ» ÃæºÐÈ÷ ¹ßÈÖÇÏ´Â µ¥ Àå¾Ö°¡ µÉ ¼ö ÀÖ´Â ¸î °¡Áö Á¦¾à¿¡ Á÷¸éÇØ ÀÖ½À´Ï´Ù. »ý¹°Á¦Á¦ Ä¡·á´Â °í°¡ÀÇ ºñ¿ëÀ¸·Î ÀÎÇØ, ƯÈ÷ ÁßÀú¼Òµæ Áö¿ª¿¡¼­´Â ±× ÀÌ¿ëÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀÌ·¯ÇÑ Ä¡·á¹ýÀº ´ëºÎºÐ Àå±â°£ »ç¿ëÇØ¾ß ÇϹǷΠȯÀÚÀÇ ÀÇ·áºñ Áõ°¡·Î À̾îÁú ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ºÎÀÛ¿ëÀÇ °¡´É¼º, ±ÔÁ¦ ´ç±¹ÀÇ ¾ö°ÝÇÑ ½ÂÀÎ, ÁÖ¿ä ¾à¹°ÀÇ Æ¯Çã ¸¸·á µîÀÌ ½ÃÀå ¿ªÇп¡ ¿µÇâÀ» ¹ÌÄ¥ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ ³óÃÌÀ̳ª Àα¸°¡ ÀûÀº Áö¿ª¿¡¼­ÀÇ ³·Àº ÀÎÁöµµµµ ÷´Ü Ä¡·áÀÇ º¸±ÞÀ» Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ±âȸ:

°Ç¼± Ä¡·áÁ¦ ½ÃÀåÀº ȯÀÚ ¼ö Áõ°¡¿Í Ä¡·á ÆÐ·¯´ÙÀÓÀÇ ÁøÈ­·Î ÀÎÇØ À¯¸ÁÇÑ ±âȸ¸¦ °¡Áö°í ÀÖ½À´Ï´Ù. ÁÖ¿ä »ý¹°Á¦Á¦ÀÇ ¹ÙÀÌ¿À½Ã¹Ð·¯ ¹× Á¦³×¸¯ ÀǾàǰÀÇ Áö¼ÓÀûÀÎ °³¹ß·Î ÀÎÇØ Ä¡·áºñ¿ëÀÌ ³·¾ÆÁö°í ³Î¸® º¸±ÞµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. »ý¸í°øÇÐ ±â¾÷°ú ´ëÇü Á¦¾à»ç¿ÍÀÇ ¿¬±¸ ¹× À¯Åë Á¦ÈÞ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ±â¼ú Çõ½Å°ú ½ÃÀå ħÅõ°¡ °¡¼ÓÈ­µÉ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¶ÇÇÑ ¸ÂÃãÇü ÀÇ·á¿Í Ç¥Àû Ä¡·áÀÇ ¹ßÀüÀº º¸´Ù Á¤È®Çϰí È¿°úÀûÀÎ Ä¡·á¸¦ À§ÇÑ »õ·Î¿î ±æÀ» ¿­¾îÁÙ °ÍÀÔ´Ï´Ù. µðÁöÅÐ Çコ Ç÷§Æû°ú ¿ø°ÝÀÇ·á ¼­ºñ½ºÀÇ È®´ë´Â ¿ø°ÝÁö¿¡¼­ÀÇ Áø´Ü ¹× Ä¡·á Á¢±Ù¼ºÀ» Çâ»ó½Ãų °ÍÀÔ´Ï´Ù.

ÀÌ º¸°í¼­¿¡¼­ ´äº¯À» ¾òÀ» ¼ö ÀÖ´Â ÁÖ¿ä Áú¹®

¸ñÂ÷

Á¦1Àå °³¿ä

Á¦2Àå ½ÃÀå °³¿ä

Á¦3Àå ºÎ°¡°¡Ä¡ ºÐ¼®

Á¦4Àå ¼¼°èÀÇ °Ç¼± Ä¡·áÁ¦ ½ÃÀå Àü¸Á :

Á¦5Àå ¼¼°èÀÇ °Ç¼± Ä¡·áÁ¦ ½ÃÀå Àü¸Á : Áö¿ªº°

Á¦6Àå ºÏ¹ÌÀÇ °Ç¼± Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦7Àå À¯·´ÀÇ °Ç¼± Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦8Àå µ¿¾Æ½Ã¾ÆÀÇ °Ç¼± Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦9Àå ³²¾Æ½Ã¾Æ¡¤¿À¼¼¾Æ´Ï¾ÆÀÇ °Ç¼± Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦10Àå ¶óÆ¾¾Æ¸Þ¸®Ä«ÀÇ °Ç¼± Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦11Àå Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ °Ç¼± Ä¡·áÁ¦ ½ÃÀå Àü¸Á

Á¦12Àå °æÀï ±¸µµ

Á¦13Àå ºÎ·Ï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Persistence Market Research has recently released a comprehensive report on the global Psoriasis Drugs Market, providing an in-depth analysis of key market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, helping stakeholders make well-informed decisions.

Key Insights:

Psoriasis Drugs Market - Report Scope:

The psoriasis drugs market includes a broad spectrum of pharmaceutical treatments aimed at managing and alleviating the symptoms of psoriasis, a chronic autoimmune skin disease. These treatments range from topical agents to advanced biologics and systemic medications. Growing awareness, technological advancements in drug development, and increasing prevalence of psoriasis globally are shaping the demand for more effective therapies. Innovation in biologic drugs and expanding access to dermatological healthcare services continue to drive market momentum.

Market Growth Drivers:

The growth of the global psoriasis drugs market is propelled by the rising prevalence of psoriasis and an increasing number of patients seeking medical treatment due to improved awareness and diagnosis. Technological advancements in biologic therapies, which offer targeted and effective treatment, have significantly expanded treatment options. Favorable reimbursement policies in developed countries and ongoing R&D efforts by pharmaceutical giants have also boosted drug pipeline development. Moreover, the expansion of healthcare infrastructure in emerging economies is facilitating greater access to psoriasis treatments, further driving market growth.

Market Restraints:

Despite the positive outlook, the market faces certain constraints that may hinder its full potential. High costs associated with biologic therapies can limit their accessibility, especially in low- and middle-income regions. Many of these treatments also require long-term use, which can lead to increased healthcare expenses for patients. Additionally, potential side effects, stringent regulatory approvals, and patent expirations for key drugs may impact market dynamics. Limited awareness in rural and underdeveloped areas also restricts the reach of advanced treatments.

Market Opportunities:

The psoriasis drugs market holds promising opportunities due to a growing patient pool and evolving treatment paradigms. The continued development of biosimilars and generic versions of key biologics is expected to make treatments more affordable and widely available. Increasing collaborations between biotech firms and pharmaceutical giants for research and distribution can accelerate innovation and market penetration. Additionally, advancements in personalized medicine and targeted therapies open new avenues for more precise and effective treatment. Expanding digital health platforms and telemedicine services can also enhance diagnosis and treatment accessibility in remote regions.

Key Questions Answered in the Report:

Competitive Intelligence and Business Strategy:

Leading companies in the global psoriasis drugs market, such as Janssen Biotech, Novartis, Amgen, and Pfizer, are prioritizing the development of next-generation biologics and expanding their global footprint through mergers and partnerships. These companies focus on enhancing therapeutic efficacy and minimizing side effects. R&D investment remains a strategic focus, particularly in immunomodulators and interleukin inhibitors. Strategic alliances with biotech startups and clinical trial expansions in developing countries are helping firms broaden their reach and drive competitive differentiation.

Companies Covered in This Report:

Market Segmentation:

By Drug Class:

By Mode of Administration:

By Indication:

By Distribution Channel:

By Region:

Table of Contents

1. Executive Summary

2. Market Overview

3. Value Added Insights

4. Global Psoriasis Drugs Market Outlook:

5. Global Psoriasis Drugs Market Outlook: Region

6. North America Psoriasis Drugs Market Outlook

7. Europe Psoriasis Drugs Market Outlook

8. East Asia Psoriasis Drugs Market Outlook

9. South Asia & Oceania Psoriasis Drugs Market Outlook

10. Latin America Psoriasis Drugs Market Outlook

11. Middle East & Africa Psoriasis Drugs Market Outlook

12. Competition Landscape

13. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â